- Details
- Diane Newman hosts Avanti Rangnekar to discuss research examining pelvic floor dysfunction and dyspareunia in elite female athletes at the University of Pennsylvania. The study investigates whether rigorous athletic training contributes to increased incidence of pelvic floor dysfunction, particularly focusing on provoked vestibulodynia (PVD) and painful intercourse among NCAA Division I athletes i...
|
- Details
- Avanti Rangnekar joins Diane Newman to discuss research examining the relationship between smoking and urinary urgency in women. The study, conducted through ResearchMatch, analyzes data from over 1,700 community-based women to evaluate both current smoking status and cumulative pack-year history's impact on overactive bladder symptoms. The findings reveal that current smokers face significantly h...
|
- Details
- Brian Flynn discusses the emerging field of functional urology. Dr. Flynn defines functional urology as a comprehensive approach to non-cancer, non-stone, adult urological issues, focusing on restoring patients' functionality. He positions it as a bridge between reconstructive and traditional urology, emphasizing the need for expertise in both surgical techniques and physiological understanding. D...
|
- Details
- At the World Congress of Endourology and Uro-Technology, Bruce Gao presents the development and evaluation of a cost-effective force sensor for ureteroscopic applications called the Air Force 1. This device uses readily available materials to measure insertion forces during ureteral access sheath placement, aiming to prevent high-grade ureteral injuries. Dr. Gao concludes that this inexpensive met...
|
- Details
- David Staskin discusses the COURAGE trial, a phase three study evaluating the efficacy of Vibegron, a beta-3 adrenergic receptor agonist, in men with BPH and persistent OAB symptoms despite alpha-blocker treatment. The study demonstrates significant improvements in various urinary symptoms, including micturitions, urgency episodes, and nocturia. Dr. Staskin highlights the drug's favorable safety p...
|
- Details
- Anticholinergic medications have long been mainstays of overactive bladder (OAB) treatment. Oxybutynin, a first-generation anticholinergic, still accounts for more than half of all OAB medication prescriptions, despite associations with impaired memory and cognition, as well as mounting evidence that it may increase the risk of incident dementia. Biographies: Michael Chancellor, MD, Corewell Healt...
|
- Details
- To improve diagnosis of IC/BPS(IC) we hereby developed an improved IC risk classification using machine learning algorithms. Biographies: Michael B. Chancellor, MD, Professor of Urology, Oakland University William Beaumont School of Medicine, Rochester, MI Related Content: Risk Classification for Interstitial Cystitis/Bladder Pain Syndrome Using Machine Learning Based Predictions Risk Classificati...
|
- Details
- Diane Newman interviews Jill Peters-Gee about her comprehensive book on interstitial cystitis (IC). Dr. Peters-Gee discusses her motivation for writing the book due to outdated resources and new information from the MAPP Network. She explains the terminology confusion between IC and bladder pain syndromes (BPS) and emphasizes the need for phenotyping to tailor treatments. They discuss the importan...
|
- Details
- Diane Newman interviews Ariana Smith about the newly released AUA/SUFU Overactive Bladder Guidelines. Dr. Smith, who co-chaired the guidelines, emphasizes the shift from a stepwise therapy approach to a patient-centered menu of treatment options. This new guideline encourages shared decision-making, allowing patients to consider all treatments upfront based on their personal values and goals. It i...
|
- Details
- Diane Newman interviews Siobhan Sutcliffe about her research on the Preventive Lower Urinary Tract Symptoms (PLUS) Consortium, specifically focusing on the Rise for Health Study. Dr. Sutcliffe explains that the study aims to understand factors promoting bladder health and preventing lower urinary tract symptoms (LUTS) in women. The cohort study, started in May 2022, includes women aged 18 and olde...
|
